Phibro Animal Health
Phibro Animal Health offers a wide range of animal health products, including vaccines, medicated feed additives, and nutritional products, and provides solutions for various animal species. The company also specializes in microbial contract manufacturing and operates divisions focused on biofuel plant optimization and plant solutions.
Services
Phibro Animal Health offers a wide range of services targeted at the animal health industry. It specializes in microbial contract manufacturing services through its division Phibro Biotechnics. Additionally, the company provides custom autogenous vaccines to address specific farm needs and ensures product quality and safety via its Dynamic Quality Assurance® (DQA®) program. Phibro Animal Health supports sustainable aquaculture practices and provides microbial-based products for seed treatments and fertilizer companions through Phibro Plant Solutions.
Products
Phibro Animal Health features a broad portfolio, including vaccines, medicated feed additives, and nutritional products. Key nutritional specialty products include OmniGen®, Animate®, AB20®, Hy•D®, and Cellerate Yeast Solutions®. The company also developed the patented TAbic® vaccine delivery platform, which uses effervescent tablets for effective vaccine antigen delivery. Moreover, Phibro introduced the pHi-Tech® vaccination management system aimed at ensuring the maximal efficacy of vaccination programs. The company is engaged in providing microbial-based products for seed treatments and enhancing fertilizer performance.
Acquisitions
Phibro Animal Health has expanded its capabilities through strategic acquisitions. It acquired MVP Laboratories, Biotay S.A., and Osprey Biotechnics, thereby enhancing its product offerings and technological expertise. In 2000, Phibro acquired the global medicated feed additive business from Pfizer Inc., adding to its portfolio and market presence.
History
Founded in 1946 under the name Philipp Brothers Chemicals, Inc., Phibro Animal Health has a storied history in the animal health sector. The company completed its initial public offering in 2014, marking a significant milestone. Over the years, Phibro has grown and evolved, acquiring substantial businesses and introducing innovative products to better serve the animal health industry.